Microglial senescence: does the brain's immune system have an expiration date?

Wolfgang J Streit1

  • 1Department of Neuroscience, PO Box 100244, University of Florida College of Medicine, Gainesville, FL 32610, USA. streit@mbi.ufl.edu

Insights

Microglia, the brain's immune cells, may undergo aging, leading to a decline in their protective functions. This cellular senescence could increase the risk of neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Cellular Biology

Background:

  • Microglia act as the central nervous system's (CNS) first responders to injury and disease.
  • These immune cells and associated macrophages are crucial for immune surveillance and neuroprotection.
  • Evidence suggests microglia in aged human brains exhibit structural deterioration and undergo replicative senescence in rodents.

Purpose of the Study:

  • To explore the possibility that aging and other factors negatively impact microglial viability and self-renewal.
  • To investigate if these factors lead to the generation of senescent or dysfunctional microglia.
  • To understand how microglial attrition may contribute to neurodegenerative disease development.

Main Methods:

  • Morphological analysis of microglia in aged human brain tissue.
  • Rodent studies investigating microglial replicative senescence.
  • Review of existing literature on microglial function and aging.

Main Results:

  • Morphological evidence indicates structural deterioration of microglia in aged human brains.
  • Rodent studies suggest microglia are susceptible to replicative senescence.
  • These findings raise concerns about the viability and self-renewal capacity of microglia in aging.

Conclusions:

  • Old age and other factors may impair microglial function, leading to senescence.
  • The generation of dysfunctional microglia could compromise the brain's immune defenses.
  • This decline in microglial neuroprotection may contribute to the pathogenesis of neurodegenerative diseases.